Erratum to: Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer
Cell Mol Life Sci
.
2017 Feb;74(3):571-577.
doi: 10.1007/s00018-016-2424-6.
Authors
Mohammad Jaber
1
,
Miriam Maoz
1
,
Arun Kancharla
1
,
Daniel Agranovich
1
,
Tamar Peretz
1
,
Sorina Grisaru-Granovsky
2
,
Beatrice Uziely
1
,
Rachel Bar-Shavit
3
Affiliations
1
Sharett-Institute of Oncology, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel.
2
Department of Obstetrics and Gynecology, Shaare-Zedek and Hadassah-Hebrew University Medical Centers, POB 12000, 1120, Jerusalem, Israel.
3
Sharett-Institute of Oncology, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel. Rachelbar@ekmd.huji.ac.il.
PMID:
27900391
DOI:
10.1007/s00018-016-2424-6
No abstract available
Publication types
Published Erratum